ANIXA BIOSCIENCES INC Shares Outstanding 2010-2022 | ANIX

ANIXA BIOSCIENCES INC shares outstanding from 2010 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
ANIXA BIOSCIENCES INC Annual Shares Outstanding
(Millions of Shares)
2022 30
2021 29
2020 22
2019 20
2018 18
2017 12
2016 9
2015 9
2014 9
2013 8
2012 7
2011 7
2010 6
2009 6
ANIXA BIOSCIENCES INC Quarterly Shares Outstanding
(Millions of Shares)
2022-10-31 30
2022-07-31 30
2022-04-30 30
2022-01-31 30
2021-10-31 29
2021-07-31 30
2021-04-30 29
2021-01-31 25
2020-10-31 22
2020-07-31 23
2020-04-30 21
2020-01-31 21
2019-10-31 20
2019-07-31 20
2019-04-30 20
2019-01-31 19
2018-10-31 18
2018-07-31 18
2018-04-30 17
2018-01-31 17
2017-10-31 12
2017-07-31 15
2017-04-30 10
2017-01-31 9
2016-10-31 9
2016-07-31 9
2016-04-30 9
2016-01-31 9
2015-10-31 9
2015-07-31 9
2015-04-30 9
2015-01-31 9
2014-10-31 9
2014-07-31 11
2014-04-30 9
2014-01-31 8
2013-10-31 8
2013-07-31 8
2013-04-30 8
2013-01-31 7
2012-10-31 7
2012-07-31 7
2012-04-30 7
2012-01-31 7
2011-10-31 7
2011-07-31 7
2011-04-30 7
2011-01-31 6
2010-10-31 6
2010-07-31 6
2010-04-30 6
2010-01-31 6
2009-10-31 6
2009-07-31 6
2009-04-30 5
2009-01-31 5
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.136B $0.001B
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $155.188B 9.47
GSK (GSK) United Kingdom $72.345B 9.01
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.333B 19.34
Ginkgo Bioworks Holdings (DNA) United States $3.395B 0.00
Myovant Sciences (MYOV) United Kingdom $2.604B 0.00
Arcus Biosciences (RCUS) United States $1.672B 25.10
Biohaven (BHVN) United States $1.264B 0.00
Emergent Biosolutions (EBS) United States $0.655B 5.15
ADC Therapeutics SA (ADCT) Switzerland $0.363B 0.00
Ambrx Biopharma (AMAM) United States $0.073B 0.00
Enzo Biochem (ENZ) United States $0.073B 0.00
Gelesis Holdings (GLS) United States $0.027B 0.00
SQZ Biotechnologies (SQZ) United States $0.025B 0.00